Following ablation for AF, GLP-1 agonist therapy is associated with decreased risk for AF recurrence in patients with type 2 diabetes. Glucagon-like peptide-1 receptor (GLP-1) agonist use is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback